Tissue repair and healing involves two processes - regeneration, where new cells replace damaged tissue, and repair through connective tissue replacement. Healing begins during the inflammatory phase as new blood vessels form (angiogenesis) and granulation tissue develops from endothelial cell migration, proliferation and recruitment of other cells. Fibroblasts are triggered by growth factors to migrate to the injury site and deposit extracellular matrix including collagen to strengthen the wound as it remodels over time. Successful healing depends on factors like nutrition, infection control and wound characteristics.
Tissue repair and healing involves two processes - regeneration, where new cells replace damaged tissue, and repair through connective tissue replacement. Healing begins during the inflammatory phase as new blood vessels form (angiogenesis) and granulation tissue develops from endothelial cell migration, proliferation and recruitment of other cells. Fibroblasts are triggered by growth factors to migrate to the injury site and deposit extracellular matrix including collagen to strengthen the wound as it remodels over time. Successful healing depends on factors like nutrition, infection control and wound characteristics.
Tissue repair and healing involves two processes - regeneration, where new cells replace damaged tissue, and repair through connective tissue replacement. Healing begins during the inflammatory phase as new blood vessels form (angiogenesis) and granulation tissue develops from endothelial cell migration, proliferation and recruitment of other cells. Fibroblasts are triggered by growth factors to migrate to the injury site and deposit extracellular matrix including collagen to strengthen the wound as it remodels over time. Successful healing depends on factors like nutrition, infection control and wound characteristics.
• REPAIR (REPLACEMENT BY CONNECTIVE TISSUE) REPAIR BEGINS DURING INFLAMMATION
NEW VESSEL FORMATION (ANGIOGENESIS)
• PROTEOLYTIC ENZYME DIGESTS BASEMENT MEMBRANE • MIGRATION OF ENDOTHELIAL CELLS • PROLIFERATION OF ENDOTHELIAL CELLS • MATURATION OF ENDOTHELIAL CELLS • RECRUITMENT OF PERIENDOTHELIAL CELLS (PERICYTES & SMOOTH MUSCLE CELLS) CONTROLLED BY: • PROMOTERS (GROWTH FACTORS) • VASCULAR CELLS & EXTRACELLULAR MATRIX • CYCLINS TYPES OF CELLS vis-à-vis THE CELL CYCLE 1. LABILE CELLS: CONTINUOUSLY IN THE CYCLE eg EPITHELIAL CELLS, SKIN, GIT, CERVIX 2. STABLE CELLS: IN Go PHASE, BUT CAN ENTER CYCLE AS REQUIRED eg. PARENCHYMAL CELLS, HEPATOCYTES, ENDOTHELIUM 3. PERMANENT CELLS: CELLS THAT HAVE LEFT THE CYCLE eg NEURONS, CARDIAC MUSCLE MOLECULAR EVENTS IN CELL GROWTH AUTOCRINE: SIGNAL FROM SAME CELL PARACRINE: SIGNAL FROM CELL NEARBY ENDOCRINE: SIGNAL FROM BLOOD STREAM CELL SURFACE RECEPTORS - FIBROBLAST GROWTH FACTOR (FGF) - EPIDERMAL GROWTH FACTOR (EGF) - PLATELET DERIVED GROWTH FACTOR (PDGF) - VASCULAR ENDITHELIAL GROWTH FACTOR (VEGF) RECEPTORS WITHOUT INTRINSIC CATALYTIC ACTIVITY - CYTOKINES G PROTEIN-LINKED RECEPTORS CHEMOKINES HEALING FOLLOWS INFLAMMATION ACUTE INFLAMMATION CHRONIC INFLAMMATION (DESTRUCTION OF PARENCHYMAL CELLS AND STROMAL FRAMEWORK) HEALING BY FIRST OR SECOND INTENTION
1. REGENERATION OF PARENCHYMAL CELLS
2. MIGRATION & PROLIFERATION OF PARENCHYMAL & CONNECTIVE TISSUE CELLS 3. SYNTHESIS OF ECM 4. REMODELLING OF CONNECTIVE TISSUE & PARENCHYMAL COMPONENTS 5. COLLAGENISATION & ACQUISITION OF WOUND STRENGTH (FIBROSIS / SCARRING) MIGRATION OF FIBROBLASTS TO THE SITE OF INJURY AND THEN PROLIFERATION AT THAT SITE. TRIGGERED BY PDGF, EGF, FGF, TGFB, CYTOKINES
DEPOSITION OF EXTRACELULAR MATRIX
FIBROBLASTS LAY DOWN COLLAGEN TYPES I, II, III = FIBRILLAR COLLAGEN TYPES IV, V, VI + AMORPHOUS (IV + BASEMENT MEMBRANE) COLLAGEN TENSILE STRENGTH TYPES I IV FIBRILS PLEATED & CROSS LINKED TO INCREASE TENSILE STRENGTH PROLINE HYDROXYPROLINE CROSS LINKAGES (PRO-COLLAGEN - COLLAGEN) STIMULATED BY PDGF, FGF, TGF-B AND CYTOKINES SECRETED BY WBC AND FIBROBLASTS MATURATION & ORGANISATION (REMODELLING) USE THE BM AS A “TEMPLATE”, NEED TO BREAK DOWN ECM IN ORDER TO DEBRIDE WOUND CONNECTIVE TISSUE REMODELLING METALLOPROTEINASES: GELATINASES (TYPE IV) STROMELYSINS COLLAGENASES (TYPES I, II & III) ECM DEGRADATION INHIBITED BY TISSUE INHIBITORS OF METALLOPROTEINASES SECRETION OF ABOVE ENZYMES INHIBITED BY TGFβ & STEROIDS FIBROBLASTS SYNTHESISE ELASTIC FIBRES AND SECRETE ECM ECM COMPRISES • COLLAGENS & ELASTINS • ADHESIVE GLYCOPROTEINS (LAMININ) & INTEGRINS • PROTEOGLYCANS & HYALURONAN FACTORS INVOLVED INFLAMMATORY RESPONSE GRANULATION TISSUES PROTEIN VITAMIN C ZINC GROWTH FACTORS FACTORS AFFECTING WOUND HEALING SYSTEMIC FACTORS: • NUTRITION- ZN, PROTEIN & VIT C DEFICIENCIES • METABOLIC STATUS – DIABETES MELLITUS • CIRCULATORY STATUS – ARTERIOSCLEROSIS • HORMONES - GLUCOCORTICOIDS LOCAL FACTORS • INFECTION • MECHANICAL FACTORS – MOBILITY • FOREIGN BODIES – UNNECESSARY SUTURES, FRAGMENTS OF GLASS, STELL, SHRAPNEL OR BONE • SIZE, LOCATION & TYPE OF WOUND PATHOLOGICAL CONDITIONS • KELOID - EXCESS COLLAGEN - GENETIC - REPEATED TRAUMA • PYOGENIC GRANULOMA “PROUD FLESH” SUMMARY - EXCESS GRANULATION TISSUE - FEMALE - SITES REPAIR BEGINS EARLY ON IN INFLAMMATION (24 HRS). BEGINS WITH THE FORMATION OF GRANULATION TISSUE (NEW VESSELS AND FIBROBLASTS) *GRANULATION TISSUE IS THE HALLMARK OF HEALING*